1. American Medical Association. AMA Code of Medical Ethics, opinion 10.05– potential patients. Adapted November 2007.
http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/opinion1005.shtml
. Accessed 14 Mar 2010.
2. American Academy of Dermatology and AAD Association. Administrative Regulation, AAD Code of Medical Ethics for Dermatologists, last revised 4 November, 2006.
http://www.aad.org/Forms/Policies/Uploads/AR/AR%20CODE%20OF%20MEDICAL%20ETHICS%20FOR%20DERMATOLOGISTS.pdf
. Accessed 25 Feb 2010.
3. American Academy of Dermatology and AAD Association. Position statement on access to specialty care and direct access to dermatological care. Approved March 21, 1997, 2006.
http://www.aad.org/Forms/Policies/Uploads/PS/PS-Access%20to%20Specialty%20Care%20and%20Direct%20Access%20to%20Dermatologic%20Care%206-15-06.pdf
. Accessed 14 Mar 2010.
4. Resneck Jr JS, Lipton S, Pletcher MJ. Short wait times for patients seeking cosmetic botulinum toxin appointments with dermatologists. J Am Acad Dermatol. 2007;57:985–9.
5. Kimball AB, Resneck Jr JS. The US dermatology workforce: a specialty remains in shortage. J Am Acad Dermatol. 2008;59:741–5.